VitaSpring Biomedical Co. Ltd.
Income Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Revenue | $16.2K | $0 |
| Cost of Revenue | $4.9K | $0 |
| Gross Profit | $11.3K | $0 |
| Gross Margin | 69.9% | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $17.7K | $45 |
| Operating Income | $-6.4K | — |
| Operating Margin | -39.3% | — |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | — | — |
| Net Income | $-6.4K | $-45 |
| Net Margin | -39.3% | — |
| EPS (Basic) | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 |
| Shares Outstanding (Basic) | — | — |
| Shares Outstanding (Diluted) | 146.8M | 148.3M |
| Dividends Per Share | — | — |